Biological markers to predict response to neoadjuvant chemotherapy (NCT) in patients with locally advanced breast cancer (LABC): Ready for prime time?
M. S. Pino
No relevant relationships to disclose
A. Fabi
No relevant relationships to disclose
M. Tedeschi
No relevant relationships to disclose
M. Mottolese
No relevant relationships to disclose
P. Papaldo
No relevant relationships to disclose
P. Vici
No relevant relationships to disclose
G. Ferretti
No relevant relationships to disclose
C. Nisticò
No relevant relationships to disclose
M. Russillo
No relevant relationships to disclose
F. Cuppone
No relevant relationships to disclose
A. Di Benedetto
No relevant relationships to disclose
C. Botti
No relevant relationships to disclose
D. Giannarelli
No relevant relationships to disclose
F. Cognetti
No relevant relationships to disclose